Biohaven

03/12/2026

reminds us of the critical role kidneys play in overall health and the urgent need for new treatments for diseases like IgA nephropathy (IgAN).This progressive kidney disease can lead to renal failure within 10 to 15 years, affecting daily life, energy, and overall health. We are committed to advancing science that targets the root cause of IgAN and improving outcomes for patients living with this disease.

Learn more at: https://brnw.ch/21x0G7B

03/09/2026

This Brain Awareness Week, we’re highlighting Parkinson’s disease as a growing public ealth challenge affecting millions worldwide. We are committed to advancing research that addresses the root drivers of this devastating disease. Neuroinflammation plays a key role in disease progression, and our investigational therapy is designed to target this pathway. Through bold science and patientfocused innovation, we are working to change the trajectory of this disease. Learn more about our work in Parkinson’s: https://brnw.ch/21x0AGs

03/08/2026

Today, on , we’re proud to celebrate the extraordinary women of Biohaven.

Their bold ideas, fearless curiosity, and unwavering dedication fuel our mission and strengthen our culture every day. From advancing science to challenging the status quo, the women on our team play a vital role in helping us deliver meaningful therapies for patients.

We are grateful for their leadership, innovation, and impact — today and every day. 💜

03/04/2026

On , we recognize obesity as a complex, chronic disease affecting millions of people worldwide. We are committed to advancing new approaches to healthier weight management, including our investigational therapy, which is designed to reduce fat while preserving muscle.

02/28/2026

Our New Haven office lit up for ! In honor of , we joined National Organization for Rare Disorders, Inc. (NORD)’s global initiative to raise awareness for those living with rare diseases. Every light symbolizes hope, support and our commitment to making a difference.

02/20/2026

On February 23, the .S. Food and Drug Administration will host its virtual Rare Disease Day, “Moving Forward. Looking Ahead. An Event for Patients.” Patients, families, care partners and advocates are encouraged to attend and learn more about the FDA’s initiatives to advance medical product development for rare disease.
Learn more and register here: https://bit.ly/4kHLo6l

The public meeting will be held on February 23, 2025, from 9 a.m. to 4 p.m ET.

02/18/2026

Emma’s journey with Graves’ disease reflects the challenges of acceptance and learning to live with a chronic condition. Her story reminds us that a diagnosis does not define a person.
To learn more about Graves’ disease, visit: UnmaskGravesDisease.com

02/11/2026

On International Day of Women and Girls in Science, we’re celebrating the women at Biohaven who lead, innovate and inspire.

02/06/2026

This , we honor the strength, resilience and courage of the patients who inspire us. You guide our mission to advance science, tackle tough challenges and deliver treatments that make a meaningful difference.

01/29/2026

At Biohaven, . We’re dedicated to advancing science with the speed and rigor that patients expect and deserve.
See what we’re working on to make a difference: https://bit.ly/4jOEmL8

01/27/2026

IgA nephropathy (IgAN) is a rare, serious kidney disease that often affects young adults and can lead to kidney failure. With no FDA-approved treatments that target the underlying cause, there’s an urgent need for new therapies and greater awareness.
To learn more about IgAN, its impact and the need for innovative treatment approaches, visit: https://bit.ly/4904Vuy

01/21/2026

This National Healthy Weight Week, we’re highlighting the importance of maintaining a healthy weight for overall health and well-being.

We are advancing research exploring an innovative approach of targeting myostatin, a natural protein that when blocked increases skeletal muscle and reduces fat. Our goal is to enhance lean muscle, reduce fat and supporting overall metabolic health.